SARS-CoV-2

Bin Ju1,2, Qi Zhang3, Jiwan Ge4

  • 1Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.

Nature
|May 27, 2020
PubMed
概括

研究人员分离出针对SARS-CoV-2受体结合域 (RBD) 的强效中和抗体. 这些抗体通过与ACE2竞争来阻止病毒的进入,从而提供潜在的COVID-19疗法.